Latest Articles

  • The apples and oranges of cost-effectiveness: A rejoinder
    Chiedozie I. Udeh, MD, MHLTHEC and Belinda L. Udeh, PhD, MPH
    Cleveland Clinic Journal of Medicine September 2012, 79 (9) 608-610; DOI: https://doi.org/10.3949/ccjm.79a.12123

    A recent CCJM commentary used straw men to indict cost-effectiveness research.

  • Flashing lights, floaters, and reduced vision
    Abdul Hamid Alraiyes, MD, M. Chadi Alraies, MD, Francisco Aécio Almeida, MD, MS and Arun D. Singh, MD
    Cleveland Clinic Journal of Medicine September 2012, 79 (9) 616-618; DOI: https://doi.org/10.3949/ccjm.79a.11141

    A 62-year-old woman has numerous lobulated, yellowish, choroidal lesions in the left eye, and two similar but smaller lesions in the right eye. What is the cause?

  • Using the ankle-brachial index to diagnose peripheral artery disease and assess cardiovascular risk
    Using the ankle-brachial index to diagnose peripheral artery disease and assess cardiovascular risk
    Esther S. H. Kim, MD, MPH, Keattiyoat Wattanakit, MD, MPH and Heather L. Gornik, MD, MHS
    Cleveland Clinic Journal of Medicine September 2012, 79 (9) 651-661; DOI: https://doi.org/10.3949/ccjm.79a.11154

    The authors seek to convince you to measure the ankle-brachial index in any patient you suspect may have peripheral artery disease, whether or not they have symptoms.

  • Immune thrombocytopenia in adults: An update
    Swapna Thota, MD, Gaurav Kistangari, MD, Hamed Daw, MD and Timothy Spiro, MD
    Cleveland Clinic Journal of Medicine September 2012, 79 (9) 641-650; DOI: https://doi.org/10.3949/ccjm.79a.11027

    Management has changed in the last decade, with new drugs and with increased awareness of treatment side effects.

  • Atrial fibrillation: New drugs, devices, and procedures
    Bruce D. Lindsay, MD
    Cleveland Clinic Journal of Medicine August 2012, 79 (8) 553-559; DOI: https://doi.org/10.3949/ccjm.79gr.12004

    An update on controversies in treating atrial fi brillation: new oral anticoagulants vs warfarin, rate control vs rhythm control, the safety of dronedarone, and the efficacy of ablation.

  • Synthetic legal intoxicating drugs
    Ravi N. Chandiramani, ND
    Cleveland Clinic Journal of Medicine August 2012, 79 (8) 534; DOI: https://doi.org/10.3949/ccjm.79c.08001

    Readers comment on synthetic legal intoxicating drugs (April 2012) and on the geriatric patient-centered medical home (May 2012).

  • In reply: Geriatric patient-centered medical home
    Amelia Gennari, MD, Kim Fedor, BSN, MBA, Eric Bakow, MA, MPM, RRT and Neil M. Resnick, MD
    Cleveland Clinic Journal of Medicine August 2012, 79 (8) 535; DOI: https://doi.org/10.3949/ccjm.79c.08004

    Readers comment on synthetic legal intoxicating drugs (April 2012) and on the geriatric patient-centered medical home (May 2012).

  • The stethoscope as metaphor
    Salvatore Mangione, MD
    Cleveland Clinic Journal of Medicine August 2012, 79 (8) 545-546; DOI: https://doi.org/10.3949/ccjm.79a.12075

    The humanities—and bedside skills—ought to be a fundamental part of medical education. The alternative is a future full of technicians with tricorders, but sorely lacking in healers.

  • Regularizing the approach to the irregularly irregular
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine August 2012, 79 (8) 522; DOI: https://doi.org/10.3949/ccjm.79b.12008

    We have more choices, more data, and more management algorithms, but still no panacea for atrial fibrillation.

  • Geriatric patient-centered medical home
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine August 2012, 79 (8) 535; DOI: https://doi.org/10.3949/ccjm.79c.07003

    Readers comment on synthetic legal intoxicating drugs (April 2012) and on the geriatric patient-centered medical home (May 2012).

Pages